BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high demand for its medicines. Its recently announced Lilly Medicine Foundry—which will support research and development efforts—is just the latest example of the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical ...
BioSpace - BioSpace
Jul 31, 2024 · BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
About Us - BioSpace
BioSpace is the hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The proprietary resources we provide help companies make informed decisions regarding their workforce. BioSpace has a …
All News - BioSpace
6 days ago · At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, President Trump issued multiple executive orders that concern the industry.
Latest News & Press Releases - BioSpace
4 days ago · Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
Companies - BioSpace
5 days ago · Dive into news, jobs and get insights on life sciences companies across the U.S.
China - BioSpace
As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune diseases, a continued appetite for next-generation obesity drugs and an increased focus on neuromuscular, kidney and cardiovascular diseases.
BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest …
Jan 7, 2025 · The members of BioSpace ’s NextGen Class of 2025 are not afraid of a challenge, diving into and tackling hurdles in some of biopharma’s most competitive spaces. For 11 years, BioSpace has highlighted the most anticipated new biopharma startups from across the U.S. This year’s class, selected from companies that announced initial, seed or series A rounds between October 2023 and September ...
BioSpace Insights - BioSpace
Dec 11, 2024 · The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.
Pipeline - BioSpace
Jan 16, 2025 · Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, bispecifics and more contributing to multifaceted regimens unique to each patient’s needs.